Concours de recrutement de bibliothécaires assistants spécialisé de classe supérieure - Session 2020

Rapport de jury des concours externe et interne de recrutement de bibliothécaires assistants spécialisés de classe supérieure, session 2020 : cadre réglementaire et administratif, données statistiques, bilan des différentes épreuves et conseils pour les futurs candidats

Prevalence of osteochondrosis in Warmblood horses in Wallonia

peer reviewedOsteochondrosis (OC), a developmental orthopaedic disease, is consecutive to a defect in the endochondral ossification process, and can result in formation of an osteochondral fragment (osteochondrosis dissecans). Our objective is to establish the prevalence of osteochondrosis in Wallonia, and describe the main observed lesions. One hundred forty-two Warmblood horses, aged from 12 to 36 months, underwent a systematic X-ray examination. Sixty-three of these horses (44.4 %) presented one or more OC lesions, 46 (32.4 %) of them with an articular fragment. This prevalence is similar to those observed in Dutch Warmblood horses (44.3 %). The localisation of the lesions was as follows: 25 (17.6 %) of the experimental group showed one or more lesions in the hindlimbs fetlocks, 23 (16.2 %) in the hocks, 21 (14.8 %) in the stifles and 14 (9.9 %) in the forelimbs fetlocks. The medial ridge of the talus is the most frequently injured anatomical site in our study. This lesion was observed in 12 horses (8.4 %), a prevalence that is by far higher than those observed in Dutch Warmblood horses (2.9 %). Not any significant difference was observed between males and females. The high prevalence and the clinical and economic consequences of this disease in the horse’s industry fully justify further research in order to improve the understanding of its pathogenic process.Ann. Méd. Vét., 2008, 152 (3), pp 131-137 Prévalence de l’ostéochondrose chez le cheval de sport en Wallonie VANDER HEYDEN L., SERTEYN D., CAUDRON I., VERWILGHEN D., DELIEGE B., LEJEUNE J.-P. Résumé : L’ostéochondrose (OC) est une affection ostéo-articulaire juvénile, consécutive à une non-ossification de l’os endochondral et pouvant entraîner la présence de fragments ostéochondraux (ostéochondrose dissécante). L’objectif de notre étude est d’établir la prévalence de cette affection en région wallonne, et de décrire les principales lésions observées. Cent quarante-deux poulains de sport nés en Wallonie, âgés de 12 à 36 mois, ont été radiographiés. Soixante-trois de ces poulains (44,4 %) montrent une ou plusieurs lésions d’OC, 46 (32,4 %) d’entre eux avec un fragment articulaire. Cette prévalence est assez proche de celle observée chez les chevaux demi-sang néerlandais (44,3 %). Au niveau localisation, vingt-cinq (17,6 %) de nos chevaux montrent une ou plusieurs lésions au niveau des boulets postérieurs, vingttrois (16,2 %) au niveau des jarrets, vingt-et-un (14,8 %) au niveau des grassets et quatorze (9,9 %) au niveau des boulets antérieurs. La lèvre médiale de la trochlée du talus est le site anatomique du jarret présentant le plus de lésions d’OC avec douze poulains atteints (8,4 %) ; cette proportion est nettement supérieure aux 2,9 % observées chez les demi-sang néerlandais (Vos, 2008). Aucune différence significative n’a été observée entre les mâles et les femelles. La prévalence élevée et les répercussions importantes de cette affection, tant du point vue clinique qu’économique dans la filière équine, justifient pleinement l’approfondissement des études qui sont réalisées sur le sujet

Measurements of the pp → ZZ production cross section and the Z → 4ℓ branching fraction, and constraints on anomalous triple gauge couplings at √s = 13 TeV

Four-lepton production in proton-proton collisions, pp -> (Z/gamma*)(Z/gamma*) -> 4l, where l = e or mu, is studied at a center-of-mass energy of 13 TeV with the CMS detector at the LHC. The data sample corresponds to an integrated luminosity of 35.9 fb(-1). The ZZ production cross section, sigma(pp -> ZZ) = 17.2 +/- 0.5 (stat) +/- 0.7 (syst) +/- 0.4 (theo) +/- 0.4 (lumi) pb, measured using events with two opposite-sign, same-flavor lepton pairs produced in the mass region 60 4l) = 4.83(-0.22)(+0.23) (stat)(-0.29)(+0.32) (syst) +/- 0.08 (theo) +/- 0.12(lumi) x 10(-6) for events with a four-lepton invariant mass in the range 80 4GeV for all opposite-sign, same-flavor lepton pairs. The results agree with standard model predictions. The invariant mass distribution of the four-lepton system is used to set limits on anomalous ZZZ and ZZ. couplings at 95% confidence level: -0.0012 < f(4)(Z) < 0.0010, -0.0010 < f(5)(Z) < 0.0013, -0.0012 < f(4)(gamma) < 0.0013, -0.0012 < f(5)(gamma) < 0.0013

Reconstruction of primary vertices at the ATLAS experiment in Run 1 proton–proton collisions at the LHC

This paper presents the method and performance of primary vertex reconstruction in proton–proton collision data recorded by the ATLAS experiment during Run 1 of the LHC. The studies presented focus on data taken during 2012 at a centre-of-mass energy of √s=8 TeV. The performance has been measured as a function of the number of interactions per bunch crossing over a wide range, from one to seventy. The measurement of the position and size of the luminous region and its use as a constraint to improve the primary vertex resolution are discussed. A longitudinal vertex position resolution of about 30μm is achieved for events with high multiplicity of reconstructed tracks. The transverse position resolution is better than 20μm and is dominated by the precision on the size of the luminous region. An analytical model is proposed to describe the primary vertex reconstruction efficiency as a function of the number of interactions per bunch crossing and of the longitudinal size of the luminous region. Agreement between the data and the predictions of this model is better than 3% up to seventy interactions per bunch crossing

Search for dark matter produced in association with bottom or top quarks in √s = 13 TeV pp collisions with the ATLAS detector

A search for weakly interacting massive particle dark matter produced in association with bottom or top quarks is presented. Final states containing third-generation quarks and miss- ing transverse momentum are considered. The analysis uses 36.1 fb−1 of proton–proton collision data recorded by the ATLAS experiment at √s = 13 TeV in 2015 and 2016. No significant excess of events above the estimated backgrounds is observed. The results are in- terpreted in the framework of simplified models of spin-0 dark-matter mediators. For colour- neutral spin-0 mediators produced in association with top quarks and decaying into a pair of dark-matter particles, mediator masses below 50 GeV are excluded assuming a dark-matter candidate mass of 1 GeV and unitary couplings. For scalar and pseudoscalar mediators produced in association with bottom quarks, the search sets limits on the production cross- section of 300 times the predicted rate for mediators with masses between 10 and 50 GeV and assuming a dark-matter mass of 1 GeV and unitary coupling. Constraints on colour- charged scalar simplified models are also presented. Assuming a dark-matter particle mass of 35 GeV, mediator particles with mass below 1.1 TeV are excluded for couplings yielding a dark-matter relic density consistent with measurements

A case of phage therapy against pandrug-resistant Achromobacter xylosoxidans in a 12-year-old lung-transplanted cystic fibrosis patient

Bacteriophages are a promising therapeutic strategy among cystic fibrosis and lung-transplanted patients, considering the high frequency of colonization/infection caused by pandrug-resistant bacteria. However, little clinical data are available regarding the use of phages for infections with Achromobacter xylosoxidans. A 12-year-old lung-transplanted cystic fibrosis patient received two rounds of phage therapy because of persistent lung infection with pandrug-resistant A. xylosoxidans. Clinical tolerance was perfect, but initial bronchoalveolar lavage (BAL) still grew A. xylosoxidans. The patient's respiratory condition slowly improved and oxygen therapy was stopped. Low-grade airway colonization by A. xylosoxidans persisted for months before samples turned negative. No re-colonisation occurred more than two years after phage therapy was performed and imipenem treatment was stopped. Whole genome sequencing indicated that the eight A. xylosoxidans isolates, collected during phage therapy, belonged to four delineated strains, whereby one had a stop mutation in a gene for a phage receptor. The dynamics of lung colonisation were documented by means of strain-specific qPCRs on different BALs. We report the first case of phage therapy for A. xylosoxidans lung infection in a lung-transplanted patient. The dynamics of airway colonization was more complex than deduced from bacterial culture, involving phage susceptible as well as phage resistant strains